Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization

Graefe's Archive for Clinical and Experimental Ophthalmology, 05/01/2012

Anti–VEGF therapy for myopic choroidal neovascularization (mCNV) is effective for vision improvement in the long term. On the other hand, development or enlargement of chorioretinal atrophy frequently occurred, and affected visual improvement. Strategies to manage atrophy should be the next step in achieving better visual outcome upon mCNV treatment.

Print Article Summary Cat 2 CME Report